Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
89Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted 227Th-Conjugate Therapy in Mice.
Broer LN, Knapen DG, Suurs FV, Moen I, Giesen D, Waaijer SJH, Indrevoll B, Ellingsen C, Kristian A, Cuthbertson AS, de Groot DA, Cole PE, de Vries EGE, Hagemann UB, Lub-de Hooge MN. Broer LN, et al. Among authors: knapen dg. J Nucl Med. 2022 Nov;63(11):1715-1721. doi: 10.2967/jnumed.121.263079. Epub 2022 Apr 14. J Nucl Med. 2022. PMID: 35422447 Free article.
Molecular imaging to support cancer immunotherapy.
van de Donk PP, Oosting SF, Knapen DG, van der Wekken AJ, Brouwers AH, Lub-de Hooge MN, de Groot DA, de Vries EG. van de Donk PP, et al. Among authors: knapen dg. J Immunother Cancer. 2022 Aug;10(8):e004949. doi: 10.1136/jitc-2022-004949. J Immunother Cancer. 2022. PMID: 35922089 Free PMC article. Review.
Opportunities on the horizon for the management of early colon cancer.
Knapen DG, de Haan JJ, Fehrmann RSN, de Vries EGE, de Groot DJA. Knapen DG, et al. Crit Rev Oncol Hematol. 2023 Mar;183:103918. doi: 10.1016/j.critrevonc.2023.103918. Epub 2023 Jan 23. Crit Rev Oncol Hematol. 2023. PMID: 36702421 Free article. Review.
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment.
Woerdenbag HJ, Olinga P, Kok EA, Brugman DAP, van Ark UF, Ramcharan AS, Lebbink PW, Hoogwater FJH, Knapen DG, de Groot DJA, Nijkamp MW. Woerdenbag HJ, et al. Among authors: knapen dg. Cancers (Basel). 2023 Apr 1;15(7):2119. doi: 10.3390/cancers15072119. Cancers (Basel). 2023. PMID: 37046779 Free PMC article. Review.
Monoclonal antibody biosimilars for cancer treatment.
Broer LN, Knapen DG, de Groot DA, Mol PGM, Kosterink JGW, de Vries EGE, Lub-de Hooge MN. Broer LN, et al. Among authors: knapen dg. iScience. 2024 May 24;27(6):110115. doi: 10.1016/j.isci.2024.110115. eCollection 2024 Jun 21. iScience. 2024. PMID: 38974466 Free PMC article. Review.
14 results